← Back to Patent Explorer
US4803081A Expired / Lapsed US ⏱️ 0.0 years remaining

New pharmaceutical preparations with extended release

Assignee: Hassle AB
•
Filing: 1987-04-03
•
Granted: 1989-02-07
•
Expires: 2007-04-03
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract An extended release perparation of an active compound with very low solubility containing the active compound dissolved or dispersed in a semi-solid or liquid non-ionic solubilizer and whereby the amount by weight of the solubilizer is at least equal to the amount by weight of the active compound as well as a process for the preparation thereof.

Inventors

  • 👤 Karl-Erik L. Falk
  • 👤 Sven M. Hugosson
  • 👤 Adam Rosinski
  • 👤 John A. Sjogren

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-02 15:55
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/48; A61K9/20; A61K9/2004; A61K9/2013; A61K31/00; A61K31/33; A61K31/395; A61K31/435; A61K31/44; A61K9/14; A61K9/16; A61K9/1605; A61K9/1617; A61K9/2022; A61K9/205; A61K9/2054

Claims Analysis

Total Claims: 19
Claim 1
Independent Claim 66 words
A solid preparation providing extended release of an active compound with very low solubility in water copmrising a solution or dispersion of an effective amount of the active compound in a semi-solid or liquid nonionic solubilizer, wherein the amount by weight of the solubilizer is at least equal to the amount by weight of the active compound, and a release controlling system to provide extended release.
Claim 2
Dependent Claim 66 words
A solid preparation providing extended release of an active compound with very low solubility in water copmrising a solution or dispersion of an effective amount of the active compound in a semi-solid or liquid nonionic solubilizer, wherein the amount by weight of the solubilizer is at least equal to the amount by weight of the active compound, and a release controlling system to provide extended release.
Claim 3
Dependent Claim 18 words
A preparation according to claim 1 wherein the non-ionic solubilizer is selected from esters and/or ethers of polyethyleneglycols.
Claim 4
Dependent Claim 22 words
A preparation according to claim 1 wherein the non-ionic solubilizer is selected from polyethoxylated fatty acids, hydroxylated fatty acids or fatty alcohols.
Claim 5
Dependent Claim 36 words
A preparation according to claim 1 wherein the non-ionic solubilizer is selected from polyethoxylated castor oil, polyethoxylated hydrogenated castor oil, a polyethoxylated fatty acid from castor oil or a polyethoxylated fatty acid from hydrogenated castor oil.
Claim 6
Dependent Claim 25 words
A preparation according to claim 4 wherein the non-ionic solubilizer is esters of hydrogenated castor oil fatty acids wit oxyethylated glycerine, especially Cremophor® 40 (BASF).
Claim 7
Dependent Claim 32 words
A preparation according to claim 1 wherein the proportions between the active compound and the solubilizer varies in the range from 1:1 to 1:10, preferably in the range from 1:2 to 1:6.
Claim 8
Dependent Claim 38 words
A preparation according to claim 1 wherein the active compound has a solubility in water of 1:1000 or less by weight and is solubilizable in the non-ionic solubilizer or in a combination of water and the non-ionic solubilizer.
Claim 9
Dependent Claim 16 words
A preparation according to claim 1 wherein the active compound comprises one or more substituted dihydropyridines.
Claim 10
Dependent Claim 12 words
A preparation according to claim 8 wherein the substituted dihydropyridine is nifedipine.
Claim 11
Dependent Claim 12 words
A preparation according to claim 8 wherein the substituted dihydropyridine is felodipine.
Claim 12
Dependent Claim 24 words
A preparation according to claim 1 wherein the release is controlled by an inert porous matrix, a diffusion retarding coating or a disintegrating coating.
Claim 13
Dependent Claim 16 words
A preparation according to claim 1 wherein the release is controlled by a hydrophilic gel system.
Claim 14
Dependent Claim 19 words
A preparation according to claim 12 wherein the hydrophilic gelforming component constitutes between 20-80% by weight of the preparation.
Claim 15
Dependent Claim 14 words
A preparation according to claim 12 wherein the hydrophilic gel system comprises hydroxypropyl methylcellulose.
Claim 16
Dependent Claim 18 words
A preparation according to claim 14 wherein the hydroxypropyl methylcellulose has a hydroxypropyl content of 4-12% by weight.
Claim 17
Dependent Claim 13 words
A preparation according to claim 12 wherein the hydrophilic gel system contains carboxypolymethylene.
Claim 18
Dependent Claim 78 words
A process for making a solid preparation that provides extended release of an active compound with very low solubility in water comprising dissolving or dispersing an effective amount of the active compound in a semi-solid or liquid nonionic solubilizer, the amount by weight of said solubilizer being at least equal to the amount by wight of the active compound, and incorporating the resulting solution or dispersion into a suitable release controlling system to form a pharmaceutical dosage unit.
Claim 19
Dependent Claim 78 words
A process for making a solid preparation that provides extended release of an active compound with very low solubility in water comprising dissolving or dispersing an effective amount of the active compound in a semi-solid or liquid nonionic solubilizer, the amount by weight of said solubilizer being at least equal to the amount by wight of the active compound, and incorporating the resulting solution or dispersion into a suitable release controlling system to form a pharmaceutical dosage unit.

References Cited (Backward Citations)

DE2714065A1 Cited
DE3024858A1 Cited
US4673564A Cited
US4562069A Cited
DE3400106A1 Cited
WO1985004100A1 Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1992-02-07 1992-08-08 1993-02-07 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1996-02-07 1996-08-08 1997-02-07 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2000-02-07 2000-08-08 2001-02-07 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag